new IV anticoagulant, Angiomax (bivalirudin)
February 2001
You'll see a new IV anticoagulant, Angiomax (bivalirudin).
It will be used as an alternative to heparin for patients undergoing angioplasty. It seems to be safer and more effective.
Patients who get Angiomax have a lower risk of serious bleeding and fewer ischemic complications...heart attack, death, or repeat revascularization procedures.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote